Delfi Diagnostics Companies
Delfi Diagnostics is a cutting-edge organization that specializes in early cancer detection through non-invasive blood tests. By utilizing artificial intelligence and genome sequencing, Delfi Diagnostics can identify specific patterns of DNA fragmentation in patients' blood, allowing for early diagnosis and treatment. Founded in 2019 and headquartered in Baltimore, Maryland, the company aims to improve cancer survival rates by detecting the disease at its most curable stage.
Investors
.png)
Employee Number:
101-250
Founded Date:
2019
Industry:
AI R&D Pharma (DPI)
Headquarters:
Baltimore, Maryland, United States